Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Rev Epidemiol Sante Publique ; 65(3): 197-208, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28392200

ABSTRACT

BACKGROUND: The literature presents conflicting results on the epigenetic effect of in vitro fertilization (IVF) on the short-term and mid-term growth of children. These contradictory results may be related to the use of heterogeneous methodologies and non-longitudinal data. The goal of this study was to compare the body mass index (BMI) of children conceived via IVF and spontaneous conception (SC) children, using longitudinal data from birth to 5 years. METHODS: This study compared 118 singleton children born after in vitro fertilization, with or without intracytoplasmic sperm injection (ICSI), selected from a pre-existing single-center cohort to 320 SC children from the same geographic area. BMI and its evolution were analyzed using the mixed-effect model during three periods: before standing acquisition (from birth to 1 year of age), during standing acquisition, and the following period from 2 to 5 years of age. RESULTS: BMI means were not significantly different between groups regardless of the period, when adjusting for confounding factors related to parents, pregnancy, and children's characteristics and lifestyle. Nevertheless, during the standing acquisition period, children born after IVF-ICSI presented a less significant decrease in BMI (P<0.05). In addition, for each period we identified influencing factors (maternal BMI, level of wealth indicator) associated with BMI. CONCLUSION: In the study population, the suspected epigenetic influence of IVF reported in the literature was not observed for BMI from birth to 5 years of age. Further investigations need to be conducted to determine if the suspected influence of IVF on adiposity could be expressed through other parameters.


Subject(s)
Body Mass Index , Child Development/physiology , Fertilization in Vitro , Fertilization/physiology , Sperm Injections, Intracytoplasmic , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Longitudinal Studies , Male , Pregnancy , Single Embryo Transfer
2.
Encephale ; 42(4): 379-81, 2016 Aug.
Article in French | MEDLINE | ID: mdl-27480390

ABSTRACT

For 25years work has been underway in France for the implementation of an alternative to public financing of health care. In the absence of progress, some regional health agencies are engaged in work related to the reallocation of public finances between psychiatric institutions. We propose a reflection with suggestion on the method proposed by the Provence Alpes Côte d'Azur Regional Health Agency. Without questioning the need for a reallocation of resources between psychiatric institutions, the method proposed here needs to evolve further to be applied in a legitimate and appropriate manner. There is a kind of urgency for a reallocation of resources between psychiatric institutions in France, but it implies a collective thinking and especially the definition of evaluation procedures for the selected models. These conditions are necessary to guarantee the quality of French psychiatry and equity in access to psychiatric care.


Subject(s)
Psychiatry/economics , France , Humans , Mental Health , National Health Programs/economics , National Health Programs/legislation & jurisprudence , National Health Programs/organization & administration , Psychiatry/legislation & jurisprudence
3.
Sante Publique ; 17(2): 233-40, 2005 Jun.
Article in French | MEDLINE | ID: mdl-16001565

ABSTRACT

UNLABELLED: The objective of this article is to take inventory of the different medical emergency care units in France as of June 30, 2003, and to describe their main characteristics. METHODOLOGY: A telephone survey was conducted which posed questions based on a standard questionnaire to the Regional Unions of Liberal Doctors, the County Advisory Boards of the Medical Orders, and the directors and managers of the existing emergency care units. RESULTS: 97 medical safe houses were inventoried, 46 of which were operational and 51 which were in development. The Ile-de-France region is the region with the highest concentration of these units either operating or under construction. A large majority of the emergency care units were created since the year 2000, and half of them are located within health care centres and the other half into separate cells either close or distant from existing health care centres. More than half of them have no other staff aside from doctors, whilst the others comprise a spectrum of personnel including secretaries, nurses, and social assistants amongst others. More than half of the doctors are paid at the cost of each consultation and per treatment and do not have a technical platform at their disposal. Usually, these emergency care units are open all night during the week and on the weekends. One-third of them collaborate with the emergency centre and ambulance service (those who respond to calls to 15) and three-quarters of them are funded by the city's Assistance Fund for the Quality of Care. CONCLUSION: It would seem advantageous that a Charter for operation and management of these establishments be drafted and implemented in order standardise these types of structures and that their supervisors implement a national and regional follow-up mechanism for the establishments in order to better evaluate the evolution in terms of health care organisation, in particular with respect to raising the level and capacity of response.


Subject(s)
Community Health Centers/statistics & numerical data , Emergency Service, Hospital/statistics & numerical data , Community Health Centers/organization & administration , Emergency Service, Hospital/organization & administration , Facility Design and Construction , France , Health Care Surveys , Humans , Workforce
4.
Nephrologie ; 24(6): 293-301, 2003.
Article in French | MEDLINE | ID: mdl-14584296

ABSTRACT

Health related quality of life (HRQOL) indicators take into account the personal perception of health, and are proposed as an alternative for efficacy indicators in medical and therapeutic decision making. They provide, due to elaboration and validation of a questionnaire, a standardised assessment of the health status perception. This paper provides a review of a variety of HRQOL instruments developed for patients suffering end-stage renal disease (ESRD). Generic instruments are designed to be applicable in general population and disease-targeted instrument are potentially more sensitive to the characteristics of a specific population. Among HRQOL instruments, we found 4 generic questionnaires (the Sickness Impact Profile, the SF 36, the Nottingham Health Profile and the EQ-5D), 3 disease-targeted questionnaires developed for ESRD patient undergoing dialysis (the Kidney Disease Quality of Life instrument, the Kidney Disease Questionnaire and the Choice Health Experience Questionnaire), 1 questionnaire specific for ESRD patients (the HRQOL questionnaire), and 2 specific disease-targeted instruments for renal transplant (the Kidney Transplant Questionnaire and the ESRD Symptom Checklist-Transplantation Module). In France, very few studies on the quality of life of ESRD patients were published; no specific questionnaire validated in French is yet published.


Subject(s)
Kidney Failure, Chronic/psychology , Quality of Life/psychology , Surveys and Questionnaires , Humans , Kidney Failure, Chronic/therapy , Kidney Transplantation/psychology , Sickness Impact Profile
5.
J Clin Pharm Ther ; 28(4): 273-7, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12911678

ABSTRACT

OBJECTIVE: To determine whether Belzer solution (Viaspan, Bristol-Myers Squibb, Brussels, Belgium), which is more expensive than Eurocollins solution, was better at preventing delayed graft function (DGF) and whether it was cost-effective as it could potentially reduce post-transplantation complications. METHOD: The risk of occurrence of complications associated with the use of these two rinsing and preserving solutions was estimated from a survey of 106 patients undergoing renal transplantation between 1 January 1993 and 31 March 1998. Both efficacy and adverse outcomes were recorded along with the costs directly associated with the transplantation procedure in the hospital setting: hospitalization, rinsing and preserving solutions, medical and technical interventions and diagnostic tests. RESULTS: For the 45 kidney grafts rinsed and preserved with Eurocollins (strategy S1: n1 = 45) the cost/graft was estimated at 40 euros. With Viaspan (strategy S2: n2 = 61) the corresponding cost/graft was 424 euros. Logistic regression analysis showed that Viaspan was better than Eurocollins solution (ebeta = 0.437; P = 0.05) in preventing DGF. Overall, S2 was less expensive than S1, from the hospital's perspective. The mean difference per patient was 278 euros, which amounts to a saving of 2% of the total cost per renal transplantation. For rinsing and preserving kidney grafts Belzer solution is therefore preferable to Eurocollins solution.


Subject(s)
Adenosine/economics , Allopurinol/economics , Glutathione/economics , Hypertonic Solutions/economics , Insulin/economics , Kidney Transplantation/economics , Kidney , Organ Preservation Solutions/economics , Raffinose/economics , Adenosine/adverse effects , Allopurinol/adverse effects , Cost Savings , Cost-Benefit Analysis , Glutathione/adverse effects , Graft Survival , Humans , Hypertonic Solutions/adverse effects , Insulin/adverse effects , Kidney Transplantation/adverse effects , Kidney Tubular Necrosis, Acute/etiology , Kidney Tubular Necrosis, Acute/prevention & control , Organ Preservation/methods , Organ Preservation Solutions/adverse effects , Raffinose/adverse effects , Retrospective Studies
6.
Gynecol Obstet Fertil ; 29(1): 21-7, 2001 Jan.
Article in French | MEDLINE | ID: mdl-11217189

ABSTRACT

The objective of this work was to evaluate hospital and postoperative costs associated with gynecologic laparoscopic surgery for benign pathologies. Hospital costs were broken down into several categories: operating room, postoperative hospitalization, pharmacy, surgical instruments, sterilization of reused equipment, food and laundry, indirect costs. The mean total costs for the hospitalization time were 8547,2 francs. Medical charges in recovery time were calculated with the help of the Social Security. These charges represented less than 5% of the total cost associated with the procedure.


Subject(s)
Gynecologic Surgical Procedures/economics , Health Care Costs , Laparoscopy/economics , Drug Costs , Female , Hospital Costs , Humans , Postoperative Care/economics , Sterilization/economics , Surgical Equipment/economics
7.
Carcinogenesis ; 18(4): 749-53, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9111210

ABSTRACT

A pilot study was conducted to determine whether any relationship exists between micronucleated cell rates of female uterine cervical epithelium and current smoking status. Cervical uterine cells obtained from 118 pre-menopausal females, seen between September 1994 and June 1995 at the Occupational Medecine Interprofessional Association (AIMT), were tested for micronucleated cells by the micronucleus assay. Of the 68 subjects taken from this population that provided a least a 1000 analysed cells, 36 were non-smokers and 32 were smokers. Age distributions were different between smokers and non-smokers but results showed that age had no effect on micronucleated cell levels. Micronucleated cervical cell rates reached 0.66% in non-smokers and 1.11% in smokers: these two levels were not statistically different. No association was noted between number of cigarettes smoked and micronucleated cell levels. Results suggested that consuming 5-20 cigarettes per day was not enough to show a smoking effect on cervical micronucleated cells. A test with a greater number of female subjects would be necessary to confirm this.


Subject(s)
Cervix Uteri/pathology , Smoking/pathology , Vaginal Smears , Adolescent , Adult , Female , Humans , Micronucleus Tests , Middle Aged
8.
J Pathol ; 181(3): 294-300, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9155715

ABSTRACT

The reduction of E-cadherin expression, which is involved in the initial step of invasion and metastasis of cancer, was investigated in 218 human breast carcinomas. Quantitative immunohistochemical assays (ICAs) were performed on frozen sections. Quantitation was assessed by processing digitized microscopic images of immunoreactions using a computerized system of image analysis (SAMBA). The results were correlated with clinicopathological data and quantitative immunodetection of other molecules. E-cadherin expression was significantly (P < 0.001) stronger in ductal carcinomas than in lobular carcinomas and stronger (P < 0.01) in low grades than in high grades, but E-cadherin was independent of lymph node status and tumour size. Also an inverse significant (P < 0.01) relationship was observed between E-cadherin expression on tissue sections and positive immunoreactions with anti-P53, MIB1 (growth fraction), and anti-c-erb-B2 product. Conversely, strong positive and anti-E-cadherin immunoreactions correlated with strong positive anti-ER and anti-PR immunoreactions (P < 0.01). No relationship was observed between E-cadherin and the results of quantitative ICAs of cathepsin D, CD31, and P-glycoprotein, assessed on consecutive sections from the same frozen tissue samples. The results show that preserved E-cadherin expression correlates with high degree of tumour differentiation, low proliferative activity, and low expression of prognostic markers. The deregulation of E-cadherin is independent of other steps of tumour invasion, such as protease digestion of extracellular matrix and angiogenesis.


Subject(s)
Biomarkers, Tumor/metabolism , Breast Neoplasms/metabolism , Cadherins/metabolism , Adult , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Cell Differentiation , Female , Humans , Image Processing, Computer-Assisted , Immunoenzyme Techniques , Middle Aged , Neoplasm Invasiveness , Neoplasm Proteins/metabolism
9.
Hum Pathol ; 28(3): 289-96, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9042792

ABSTRACT

CD44 variants carrying sequences encoded by exon v6 are preferentially expressed in metastatic animal cancer cell lines. CD44v6 overexpression correlates tumor dedifferentiation and progression in some human carcinomas, but the relationship of CD44v6 overexpression with metastatic behavior of tumor observed in animal models is controversial, particularly in breast carcinomas. The discrepancies probably result from analytical bias. We investigated CD44v6 and CD44s expression in 218 frozen samples of primary breast carcinomas. Immunocytochemical procedure was performed under optimal technical conditions using commercially available 2F-10 monoclonal antibody (MAb), a microprocessor-controlled automated device (Ventana Medical Systems, Tucson, AZ), and quantitative evaluation of results by processing digitized-colored microscopic images (SAMBA, Grenoble, France). CD44v6 expression in tissue sections was shown to be independent of the patient age, tumor size, histological types and grades, and the lymph node status. CD44v6 expression was also independent of the expression of molecules endowed with poor prognostic significance detected by MAbs (anti-p53, anti-c-erb B-2 protein, MIB1) on consecutive sections. No significant relationship could be evidenced either between CD44v6 expression, and CD31 involved stromal angiogenesis and cathepsin D. Finally, CD44v6 was independent of markers of hormone dependence (estrogen and progesterone receptors, pS2) and of multidrug resistance (P-glycoprotein). Similar results were observed with anti-CD44s. We conclude that the true prognostic significance of CD44v6 overexpression still remains to be shown under rigorous technical conditions (frozen samples, well-documented MAbs, and optimal standardization of procedure using automation and quantitative analysis) providing data appropriate for further correlation with long-term patient follow-up.


Subject(s)
Breast Neoplasms/metabolism , Hyaluronan Receptors/analysis , Immunohistochemistry/methods , Adult , Aged , Aged, 80 and over , Automation , Densitometry , Epithelium/chemistry , Humans , Image Processing, Computer-Assisted , Lymphocytes/chemistry , Middle Aged
11.
Br J Cancer ; 76(3): 340-6, 1997.
Article in English | MEDLINE | ID: mdl-9252201

ABSTRACT

Expression of the bcl-2 gene was investigated in 218 human breast carcinomas by immunohistochemical analysis. Immunodetections were assessed using (1) frozen sections, (2) documented commercially available monoclonal antibody (bcl-2/124, Dako), (3) automation of immunoperoxidase technique (Ventana) and (4) quantitative evaluation of results by image analysis (SAMBA) and statistical analysis of quantitative data (BMDP software). Bcl-2 protein expression was correlated with current prognostic indicators and with molecular markers detected by the same procedure as for Bcl-2. It was shown that Bcl-2 expression is not related to patients' age, tumour size and type or lymph node status, but an inverse relationship was observed between Bcl-2 and tumour grade (P < 0.0001). An inverse relationship was also observed between Bcl-2 expression and p53 (P < 0.0001), Ki67/MIB1 antigen- (P = 0.0012), and P-gp- (P = 0.002) positive immunoreactions. In contrast, anti-Bcl-2 positive reaction was significantly associated with ER-positive (P < 0.001) and with ER/PR-positive or ER/PR/pS2-positive immunoreactions (P < or = 0.005). Bcl-2 expression was independent of CD31 and cathepsin D expression. Thus, Bcl-2 protein, thought to be antiapoptotic, exhibits parodoxical expression in human breast carcinomas. It is strongly detected in low-grade tumours (well-differentiated) with low (MIB1) growth fraction, but is independent of the tumour progression (size, node status, CD31, and cathepsin D). Bcl-2 acting on apoptosis is related to p53 gene abnormalities in breast carcinomas. Bcl-2 protein expression may also be involved in response to endocrine therapy (associated to ER/PR/pS2 positive immunoreactions) and probably with chemoresistance mechanisms (inverse relationship with P-gp).


Subject(s)
Breast Neoplasms/chemistry , Proto-Oncogene Proteins c-bcl-2/analysis , ATP Binding Cassette Transporter, Subfamily B, Member 1/analysis , Adult , Aged , Automation , Biomarkers, Tumor/analysis , Cathepsin D/analysis , Humans , Image Processing, Computer-Assisted , Immunohistochemistry/methods , Middle Aged , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Tissue Distribution
12.
Am J Clin Pathol ; 106(5): 640-6, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8929475

ABSTRACT

A series of 222 tumor samples stored at -80 degrees C in the authors' tumor library were investigated with anti-p53 (PA 1801) and streptavidin-biotin-peroxidase complex. The p53 immunoprecipitates were quantified by densitometry assessed by image analysis of digitized microscopic images. Two parameters, percentage of positive surface and mean optical densities, were compared with the patient's outcome (follow-up = 96.8 months) (life table method, Mantel Cox test, BMDP statistical software). The p53 expression significantly correlated with a poor overall survival (P = .0063), metastasis-free survival (P = .024), and recurrence-free survival (P = .022) at a 20% cutoff point of positive immunoreactive tumor surface. A strong prognostic significance was observed in the node-positive subset of patients but not in the node-negative subset, except for recurrence-free survival (P = .047). The results indicate the clinical relevance p53 evaluated by quantitative immunocytochemistry.


Subject(s)
Breast Neoplasms/pathology , Carcinoma in Situ/pathology , Carcinoma/pathology , Immunohistochemistry/methods , Tumor Suppressor Protein p53/analysis , Adult , Aged , Aged, 80 and over , Breast Neoplasms/chemistry , Breast Neoplasms/surgery , Carcinoma/chemistry , Carcinoma/surgery , Carcinoma in Situ/chemistry , Carcinoma in Situ/surgery , Female , Frozen Sections , Humans , Image Cytometry , Immunoenzyme Techniques , Middle Aged , Prognosis , Survival Rate
13.
Mutat Res ; 354(1): 1-7, 1996 Jul 05.
Article in English | MEDLINE | ID: mdl-8692195

ABSTRACT

Micronuclei observed in exfoliated cells result from DNA-damage of basal epithelium's cells by mutagens. Exfoliated urothelial cells can be collected by non-invasive procedure and may be used as target site to identify genotoxic effects of chemicals. Kinetic studies are important for any biomarker, especially those in which tissue differentiation and maturation processes will heavily influence the time between induction of damage and collection of damaged cells for analysis. This manuscript details the result of a longitudinal study of micronuclei induction in cells isolated from urine samples of 4 healthy women over 6 consecutive days. Three of them were former smokers. Results suggested that micronucleated cell rates were not influenced neither by the day nor by the time of sampling.


Subject(s)
Micronuclei, Chromosome-Defective/drug effects , Mutagens/toxicity , Ureter/drug effects , Urinary Bladder/drug effects , Adult , Female , Humans , Kinetics , Middle Aged , Occupational Exposure/adverse effects , Smoking/adverse effects , Ureter/ultrastructure , Urinary Bladder/ultrastructure , Urinary Bladder Neoplasms/etiology
14.
Int J Oncol ; 9(2): 337-44, 1996 Aug.
Article in English | MEDLINE | ID: mdl-21541520

ABSTRACT

The prognostic significance of Ki 67/MIB1 immunohistochemical assays (ICAs) was investigated in optimal technical conditions in 139 breast carcinomas. Automated ICAs (immunoperoxidase/Ventana device) was performed on frozen sections. Immunoprecipitates were quantified by computerized analysis (SAMBA) of digitized microscopic images. Mean positive surfaces (%) and quantitative immunocytochemical (QIC) index were correlated to the patients survival (8-year survival). The results showed that Ki 67/MIB1 large surfaces (cutpoint, 20%) and high QIC index (cutpoint, 12) correlated with poor overall survival (Kaplan Meier, log rank test, p=0.011 and p=0.037, BMDP software). In node positive, but not in node negative patients, large Ki 67/MIB1 surface (cutpoint, 20%) and high QIC index (cut-off 12) correlated with the overall patient survival (p=0.0037 and p=0.049). Also large Ki 67/MIB1 positive surface (cut-off, 20%) correlated with disease-free survival in all patients and node positive patients (p=0.022 and p=0.0057) but not in node negative patients. It is concluded that in optimal technical conditions (automated and quantitative immunohistochemical assays on frozen sections) Ki 67 antigen immunohistochemical expression in breast carcinomas tissue has a prognostic significance in node positive patients but not in node negative patients.

15.
Anticancer Res ; 15(6B): 2611-7, 1995.
Article in English | MEDLINE | ID: mdl-8669834

ABSTRACT

Paraffin sections of 185 breast carcinomas were reexamined in order to compare the current SBR histoprognostic grade (SBR) with to modified methods of grading recently proposed by two groups, Le Doussal et al (MSBR) and Elston et al (SBR-Elston). In each tumor, the SBR, MSBR, SBR-Elston, and each of their components were correlated with recurrence, metastases and survival rates (follow up 7 to 96 months, m = 52, SD = 19) (Kaplan-Meier test). The Nottingham prognostic index (NPI) was computed for each patient, the histological type reevaluated and both were also correlated with the patient follow up. Our results show that the three methods of grading were significantly (p < 0.0001) correlated. The three grades, were significantly correlated with metastases and survival, but not with the recurrence rates. The differentiation, the nuclear pleomorphism and the mitoses count also correlated with the metastases rate and overall survival but the mitoses number appeared to be a stronger prognostic indicator. The MSBR grading made it possible to refine the prognostic of the tumors usually scored as SBR grade 2. The NPI significantly correlated with metastases and survival (p < 0.0001), whereas the histological types were found to have no prognostic significance.


Subject(s)
Breast Neoplasms/pathology , Carcinoma/pathology , Adult , Aged , Aged, 80 and over , Breast Neoplasms/mortality , Carcinoma/classification , Carcinoma/mortality , Female , Humans , Life Tables , Middle Aged , Neoplasm Metastasis , Neoplasm Recurrence, Local/epidemiology , Prognosis , Retrospective Studies , Survival Analysis , Survival Rate
16.
Anal Quant Cytol Histol ; 17(4): 230-40, 1995 Aug.
Article in English | MEDLINE | ID: mdl-8526947

ABSTRACT

A series of 104 nonpalpable breast lesions detected by mammograms and containing microcalcifications were studied. Intraoperative radiographs of intact and sliced specimens were assessed, followed by microscopic diagnosis on frozen sections of areas containing microcalcifications. Microcalcifications detected on mammograms and radiographs of the specimens were digitized and evaluated in accordance with morphometric parameters, including the mean surface, shape factor, bend energy, envelope surface and total surface, total number and concentration of microcalcifications. Benign disorders, atypical hyperplasia and carcinomas accounted for 47.2%, 4.8% and 48% of the tissue lesions, respectively, but the disorders were most often heterogeneous and mixed. Most, but not all, parameters significantly correlated with the three types of radiographs, although radiographs of the sliced specimens provided images of the best quality. Only two parameters, mean size and bend energy, were significantly different (P = .008, .0036) in benign and malignant lesions. It is concluded that image analysis of digitized microcalcifications in radiographs may provide quantitative data helpful in mammogram interpretation.


Subject(s)
Breast Neoplasms/diagnostic imaging , Breast Neoplasms/pathology , Calcinosis/pathology , Calcinosis/diagnostic imaging , Carcinoma in Situ/diagnostic imaging , Carcinoma in Situ/pathology , Carcinoma, Intraductal, Noninfiltrating/diagnostic imaging , Carcinoma, Intraductal, Noninfiltrating/pathology , Carcinoma, Lobular/diagnostic imaging , Carcinoma, Lobular/pathology , Female , Humans , Mammography , Radiographic Image Enhancement/methods , Sensitivity and Specificity
17.
Am J Clin Pathol ; 103(4): 443-8, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7726141

ABSTRACT

The distribution of PECAM-1/CD31 molecule was investigated in 133 breast carcinomas using monoclonal antibody and frozen sections. Anti-CD31 labels endothelial cells and reflects stromal angiogenesis. The CD31 immunoreactivity was evaluated by computer-assisted analysis of digitized microscopic images. The automatic screening of the whole preparation and the measurements of the mean CD31 immunostained surface was performed in each case. A similar procedure was achieved for p53, cathepsin D, P-gp, pHER-2/neu, Ki67, pS2 estrogen and progesterone antigenic sites immunodetection. The image analysis of positive CD31 surface was variable, ranging from 4% to 33% (mean 14.7%, SD = 5.43). The CD31 positive surface correlated (P < .01) with the Nottingham prognostic index, but not with the tumor size, the node status, the tumor grade, nor with the patient age. Also the CD31 immunoreactivity was independent of the pHER-2/neu, Ki67 antigen, p53, ER, PR and pS2 immunodetectable expression in tumors, but correlates with that of cathepsin D (P = .024) and P-gp (P = .028), which reflects the multi-drug resistance capacity of tumor cells. In conclusion, CD31 positive vessels assessed on frozen sections by image analysis constitute an excellent method of evaluating tumor stromal angiogenesis, and can be further used for clinical purposes. The results also suggest that the CD31/PECAM molecule may be involved in the spread of tumor by interacting with extracellular matrix lysis that results from the tumor cell proteasic activity and with multidrug resistance.


Subject(s)
Antigens, Differentiation, Myelomonocytic/analysis , Breast Neoplasms/immunology , Carcinoma/immunology , Cell Adhesion Molecules/analysis , Adult , Aged , Aged, 80 and over , Breast Neoplasms/metabolism , Carcinoma/metabolism , Cathepsin D/metabolism , Female , Humans , Image Processing, Computer-Assisted , Immunohistochemistry , Middle Aged , Platelet Endothelial Cell Adhesion Molecule-1 , Prognosis , Receptors, Estrogen/metabolism , Tissue Distribution
18.
Hum Pathol ; 26(2): 159-66, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7860046

ABSTRACT

A series of 200 breast carcinomas was investigated on frozen sections using PAb 1801 p53 monoclonal antibody and streptavidin biotin peroxidase complex. Densitometric analysis of the immunoprecipitates was assessed by processing digitized microscopic images. p53 was observed in the nucleus of 48% of the tumors. Some tumors (14 of 91) tested in parallel on paraffin sections were negative, although positive on frozen sections. Image analysis showed that the surfaces positive with anti-p53 and the staining intensity were decreased (P < .01) on paraffin sections. The p53 tumor expression was independent of patient age, tumor size, axillary lymph node status, HER-2/neu and cathepsin D expression, and nuclear morphometric parameters. However, p53 correlated with high histological grade (P < .01), lack of estrogen receptor (ER) (P = .0015) and progesterone (PR) (P = .0065) antigenic sites, pS2 detection (P = .03), high Ki-67 immunoreactivity (P = .018), large silver-stained nucleolar organizer region (AgNOR) nuclear surface ratio (P < .02), and degree of hyperploidy (P < .03), and was more often observed in the comedocarcinomas. The results suggest that p53 expression in breast carcinomas is not a totally independent prognostic indicator and that the clinical relevance and prognostic significance of p53 expression in breast carcinomas can be reliably assessed provided that the procedures are standardized, particularly with regard to the use of frozen sections and image analysis processing of the immunodetection.


Subject(s)
Breast Neoplasms/genetics , Genes, p53 , Adult , Aged , Aged, 80 and over , Breast Neoplasms/chemistry , Breast Neoplasms/pathology , Cathepsin D/analysis , Cell Nucleus/ultrastructure , Frozen Sections , Genes, erbB-2 , Humans , Image Processing, Computer-Assisted , Immunohistochemistry , Middle Aged , Neoplasm Proteins/analysis , Nucleolus Organizer Region/ultrastructure , Ploidies , Prognosis , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis
19.
J Neurosurg ; 81(5): 765-73, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7523635

ABSTRACT

Quantitative imaging of estrogen receptors (ER's), progesterone receptors (PR's), estrogen-regulated protein (pS2), and growth fraction (Ki67) immunocytochemical assays were performed in 52 meningiomas. The results were correlated with clinical (age, sex, hormonal status, and tumor volume and location) and morphological (histological types and grades) data. The authors observed a lack of ER's in all meningiomas but the presence of PR's in 53% of these meningiomas. The immunoreactivity was restricted to tumor cell nuclei. The PR immunocytochemical assay was correlated with tumor location, histological type, histological grade, and pS2 immunocytochemical assay, but not with Ki67 immunocytochemical assay; high PR content was observed in cisternae, transitional, meningothelial, and low-grade meningiomas. Only 11 meningiomas showed more than 1% Ki67 immunoreactive nuclei. These meningiomas were usually located in the convexity and were of high histological grade. Estrogen-regulated protein immunoreactivity was observed in 34 meningiomas but the number of immunoreactive nuclei was low. The pS2 immunocytochemical assay was not related to clinicopathological features but was preferentially observed in PR-negative meningiomas. The results of this study are compared with those previously reported, and the function and regulation of PR's in meningiomas is discussed. The results indicate that 1) regulation of PR's and pS2 proteins in meningiomas differs from regulation in estrogen-dependent tissues such as breast or endometrium; 2) interruption of hormonal therapy in women presenting with a meningioma is not absolutely necessary; 3) meningiomas have different biological properties according to their clinicopathological features; and 4) future studies of hormonal clinical trials should be performed on well-defined meningioma subgroups.


Subject(s)
Meningioma/ultrastructure , Neoplasm Proteins/analysis , Nuclear Proteins/analysis , Receptors, Estrogen/ultrastructure , Receptors, Progesterone/ultrastructure , Adolescent , Adult , Aged , Aged, 80 and over , Cell Nucleolus/ultrastructure , Cell Nucleus/ultrastructure , Cytoplasm/ultrastructure , Densitometry , Female , Glioma/ultrastructure , Humans , Image Processing, Computer-Assisted , Immunohistochemistry , Ki-67 Antigen , Male , Microscopy, Electron , Middle Aged , Neurilemmoma/ultrastructure , Staining and Labeling
20.
Neuropathol Appl Neurobiol ; 20(5): 439-47, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7531297

ABSTRACT

PDGFs and their receptors expression were examined in a series of 46 meningiomas by using specific monoclonal antibodies. The immunostaining was quantified by an image analyser and the results correlated with clinical and morphological data (histological type and grade). In addition, since the PDGFB chain is encoded by the c-sis proto-oncogene localized on chromosome 22 and because monosomy 22 has been frequently reported in meningiomas, PDGFs and PDGFRs expression have been correlated with cytogenetic analysis performed in 29 cases. The results demonstrate PDGF A and PDGF B expression in most meningioma specimens and co-expression of these growth factors in numerous cells. PDGF A and B immunoreactivity was related to histological grade. PDGFR beta expression was strong in almost all meningiomas whereas PDGFR alpha was low. PDGFR alpha expression was related to tumour location and grade and PDGFR beta to histological subtype only. The cytogenetic analysis was not related to PDGFB chain expression. Taken together these data further confirm PDGF and PDGFR expression in human meningioma; PDGF may exist as an heterodimer (AB) as well as its receptor. The lack of correlation between cytogenetic analysis and PDGF values, the low level of PDGFB in recurrent meningiomas suggests that it is unlikely that the c-sis proto-oncogene plays an important role in the genesis of meningiomas.


Subject(s)
Meningeal Neoplasms/metabolism , Meningioma/metabolism , Platelet-Derived Growth Factor/metabolism , Receptors, Platelet-Derived Growth Factor/metabolism , Adult , Aged , Aged, 80 and over , Antibodies, Monoclonal , Female , Humans , Immunologic Techniques , Isomerism , Karyotyping , Male , Meningeal Neoplasms/genetics , Meningeal Neoplasms/pathology , Meningioma/genetics , Meningioma/pathology , Middle Aged , Proto-Oncogene Mas , Staining and Labeling
SELECTION OF CITATIONS
SEARCH DETAIL
...